Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-02

Clinical Trial Update: Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial exploring repurposing metformin as an anticancer agent for advanced prostate cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Mansoura University | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN